ACADIA Pharmaceuticals, Inc. (ACAD) Reports First Quarter 2013 Financial Results
5/8/2013 7:46:45 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced its unaudited financial results for the first quarter ended March 31, 2013.
Help employers find you! Check out all the jobs and post your resume.